UTAA09 injection
UCART-19-002
Phase 1 mab active
Quick answer
UTAA09 injection for Recurrent or Refractory B-cell Non Hodgkin's Lymphoma is a Phase 1 program (mab) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- Recurrent or Refractory B-cell Non Hodgkin's Lymphoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active